Silvia Koder
Medical University of Vienna
32 Papers
88 Citations
Silvia Koder is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Lupus anticoagulant & Medicine. The author has an hindex of 15, co-authored 29 publications.
Chat about Author
Papers
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Cihan Ay,Ralph Simanek,Rainer Vormittag,Daniela Dunkler,Guelay Alguel,Silvia Koder,Gabriela Kornek,Christine Marosi,Oswald Wagner,Christoph C. Zielinski,Ingrid Pabinger +10 more
TL;DR: Elevated sP-selectin (cutoff level, 53.1 ng/mL, 75th percentile of study population) was a statistically significant risk factor for VTE after adjustment for age, sex, surgery, chemotherapy, and radiotherapy (hazard ratio, 2.6, 95% confidence interval, 1.4-4.9, P = .003).
419
Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study
Cihan Ay,Daniela Dunkler,Ralph Simanek,Johannes Thaler,Silvia Koder,Christine Marosi,Christoph C. Zielinski,Ingrid Pabinger +7 more
TL;DR: Investigation of thrombin generation, a key process in hemostasis, as predictor of cancer-associated venous thromboembolism found it to help identify patients with cancer at high risk of VTE.
226
High Concentrations of Soluble P-Selectin Are Associated with Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant
Cihan Ay,Lea V. Jungbauer,Thomas Sailer,Theres Tengler,Silvia Koder,Alexandra Kaider,Simon Panzer,Peter Quehenberger,Ingrid Pabinger,Christine Mannhalter +9 more
TL;DR: Increased sP-selectin concentrations are associated with VTE and genotype status, and are lower in individuals carrying the P- selectin Pro715 variant than in those without this variant.
137
Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
Johanna Gebhart,Florian Posch,Silvia Koder,Thomas Perkmann,Peter Quehenberger,Claudia Zoghlami,Cihan Ay,Ingrid Pabinger +7 more
TL;DR: It is concluded that occurrence of a thrombotic event is associated with higher mortality in patients with LA, and the prevention of thromboembolic events in LA positives might improve survival.
70
Association of platelet activation markers with cancer-associated venous thromboembolism
Julia Riedl,Lena Hell,Alexandra Kaider,Silvia Koder,Christine Marosi,Christoph C. Zielinski,Simon Panzer,Ingrid Pabinger,Cihan Ay +8 more
TL;DR: It is concluded that sP-selectin, but not sCD40L, TSP-1 or PF-4 were associated with risk of VTE in cancer patients in this nested case–control study.